Asia-Pacific Gastroparesis Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Idiopathic, Diabetic, Post-Surgical, and Others), Drug Class (Prokinetic Agents, Botulinum Toxin Injections, and Antiemetic Agents), and Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others)

No. of Pages: 109    |    Report Code: TIPRE00024820    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia-Pacific Gastroparesis Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Gastroparesis Market – By Type

1.3.2        APAC Gastroparesis Market – By Drug Class Type

1.3.3        APAC Gastroparesis Market – By Distribution Channel

1.3.4        APAC Gastroparesis Market – By Country

2.           APAC Gastroparesis Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Gastroparesis Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Expert Opinion

5.           APAC Gastroparesis Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Diabetes Mellitus is Becoming More Common

5.1.2        Geriatric Population is Growing

5.2         Market Restraints

5.2.1        Adverse Effects of Gastroparesis Drugs

5.3         Market Opportunities

5.3.1        Research Funding on Rise

5.4         Future Trends

5.4.1        High Focus on Gastric Electrical Stimulation Therapy Research

5.5         Impact Analysis

6.           Gastroparesis Market – APAC Analysis

6.1         APAC Gastroparesis Market Revenue Forecast and Analysis

7.           APAC Gastroparesis Market Analysis – By Type

7.1         Overview

7.2         APAC Gastroparesis Market Revenue Share, by Type (2019 and 2027)

7.3         Idiopathic

7.3.1        Overview

7.3.2        Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Diabetic

7.4.1        Overview

7.4.2        Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Post-Surgical

7.5.1        Overview

7.5.2        Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.           APAC Gastroparesis Market Analysis – By Drug Class Type

8.1         Overview

8.2         APAC Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

8.3         Prokinetic Agents

8.3.1        Overview

8.3.2        Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Botulinum Toxin Injection

8.4.1        Overview

8.4.2        Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Antiemetic Agents

8.5.1        Overview

8.5.2        Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.           APAC Gastroparesis Market Analysis – By Distribution Channel

9.1         Overview

9.2         APAC Gastroparesis Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Retail Pharmacies

9.3.1        Overview

9.3.2        Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Hospital Pharmacies

9.4.1        Overview

9.4.2        Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

10.        APAC Gastroparesis Market – Country Analysis

10.1      Overview

10.1.1     APAC: Gastroparesis Market, by Country, 2019 & 2027 (%)

10.1.2     China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1       China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2       China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.3       China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.4       China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.3     Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.3       Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.4       Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.4     India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.3       India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.4.4       India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.5     South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.5.3       South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.5.4       South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6     Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.6.3       Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.6.4       Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.7     Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Rest of APAC Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Rest of APAC Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Rest of APAC Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on APAC Gastroparesis Market

11.1      APAC: Impact Assessment of COVID-19 Pandemic

12.        Gastroparesis Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Gastroparesis Market, 2018-2020

12.3      Inorganic Growth Strategies

12.3.1     Overview

12.4      Organic Growth Strategies

12.4.1     Overview

13.        Company Profiles

13.1      Allergan Plc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Bausch Health Companies Inc. (Salix Pharmaceuticals)

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Johnson and Johnson Services, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Pfizer Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Ipca Laboratories Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             China Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 2.             China Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             China Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4.             Japan Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5.             Japan Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Japan Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             India Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             India Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             India Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Korea Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          South Korea Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          South Korea Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Australia Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Australia Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Australia Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 16.          Rest of APAC Gastroparesis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 17.          Rest of APAC Gastroparesis Market, by Drug Class Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Rest of APAC Gastroparesis Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 19.          Recent Inorganic Growth Strategies in the Gastroparesis market

Table 20.          Glossary of Terms, Gastroparesis Market

LIST OF FIGURES

Figure 1.           APAC Gastroparesis Market Segmentation

Figure 2.           APAC Gastroparesis Market Segmentation, By Country

Figure 3.           APAC Gastroparesis Market Overview

Figure 4.           Idiopathic Segment Held Largest Share of APAC Gastroparesis Market

Figure 5.           India to Show Remarkable Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           APAC Gastroparesis Market Impact Analysis of Drivers and Restraints

Figure 8.           APAC Gastroparesis Market – Revenue Forecast And Analysis – 2019- 2027

Figure 9.           APAC Gastroparesis Market Revenue Share, by Type (2019 and 2027)

Figure 10.        APAC Idiopathic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        APAC Diabetic: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        APAC Post-Surgical: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        APAC Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        APAC Gastroparesis Market Revenue Share, by Drug Class Type (2019 and 2027)

Figure 15.        APAC Prokinetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        APAC Botulinum Toxin Injection: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        APAC Antiemetic Agents: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        APAC Gastroparesis Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 19.        APAC Retail Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        APAC Hospital Pharmacies: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        APAC Others: Gastroparesis Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        APAC: Gastroparesis Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        China: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Japan: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.        India: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        South Korea: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Australia: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Rest of APAC: Gastroparesis Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Impact of COVID-19 Pandemic on Gastroparesis Market in APAC Countries

Figure 30.        Growth Strategies in the Gastroparesis Market, 2018-2020

The List of Companies - Asia-Pacific Gastroparesis Market

  1. Allergan Plc
  2. Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
  3. Ipca Laboratories Ltd.
  4. Johnson and Johnson Services, Inc.
  5. Pfizer Inc.
  6. TEVA PHARMACEUTICAL INDUSTRIES LTD